Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies

Internal Medicine

Volumn 49, Issue 5, 2010, Pages 361-369

  Koreeda, Yoshimizu ^a   Higashimoto, Ikkou ^a   Yamamoto, Masuki ^a   Takahashi, Mikiko ^b   Kaji, Kenzo ^c   Fujimoto, Manabu ^c   Kuwana, Masataka ^d   Fukuda, Yuh ^b  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti aminoacyl tRNA synthetase autoantibodies; Interstitial lung disease; Myositis

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; AUTOANTIBODY; AUTOANTIBODY EJ; AUTOANTIBODY KS; AUTOANTIBODY OJ; CORTICOSTEROID; CYCLOSPORIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CAUSE OF DEATH; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DETERIORATION; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LABORATORY TEST; LUNG BIOPSY; MALE; MYOSITIS; ORGANIZING PNEUMONIA; POLYMYOSITIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENAL CORTEX HORMONES; ADULT; AGED; AMINO ACYL-TRNA SYNTHETASES; AUTOANTIBODIES; CYCLOSPORINE; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77749321069     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2889     Document Type: Article

References (28)

1. Hirakata M, Suwa A, Nagai S, et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. J Immunol 162: 2315-2320, 1999.
2. Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N. Antisynthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia. Rheumatology 46: 1005-1008, 2007.
3. Hashish L, Trieu EP, Sadanandan P, Targoff IN. Identification of autoantibodies to tyrosyl-tRNA synthetase in dermatomyositis with features consistent with anti-synthetase syndrome. Arthritis Rheum 52(Suppl 9): S312, 2005.
4. Bohan A, Peter JB. Polymyositis and dermatomyositis (parts 1 and 2). N Engl J Med 292: 344-347, 403-407, 1975.
5. American Thoracic Society/European Respiratory Society. ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165: 277-304, 2002.
6. Katzenstein ALA, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 18: 136-147, 1994.
7. American Thoracic Society/European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 161: 646-664, 2000.
8. Targoff IN. Immune manifestations of inflammatory muscle disease. Rheum Dis Clin North Am 20: 857-880, 1994.
9. Sato S, Kuwana M, Hirakata M. Clinical characteristics of Japanese patients with anti-OJ (anti-isoleucyl-tRNA synthetase) autoantibodies. Rheumatology (Oxford) 46: 842-845, 2007.
10. Hirakata M, Suwa A, Takada T, et al. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase. Arthritis Rheum 56: 1295-1303, 2007.
11. Gelpí C, Kanterewicz E, Gratacos J, Targoff IN, Rodriguez-Sanchez JL. Coexistence of two antisynthetases in a patient with the antisynthetase syndrome. Arthritis Rheum 39: 692-697, 1996.
12. Yoshifuji H, Fujii T, Kobayashi S, et al. Anti-aminoacyl-tRNA synthetase antibodies in clinical course prediction of interstitial lung disease complicated with idiopathic inflammatory myopathies. Autoimmunity 39: 233-241, 2006.
13. Hirakata M. Anti-aminoacyl-tRNA synthetase syndrome - antisynthetase syndrome -. Rinsho Meneki (Clin Immunol) 37: 472-478, 2002 (in Japanese).
14. Hirakata M. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions. Nihon Rinsho Meneki Gakkai Kaishi (Jpn J Clin Immunol) 30: 444-454, 2007 (in Japanese, Abstract in English).
15. Matsushita T, Hasegawa N, Fujimoto M, et al. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol 34: 1012-1018, 2007.
16. Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. Arthritis Rheum 26: 604-611, 1983.
17. Vázquez-Abad D, Rothfield NF. Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis. Arthritis Rheum 39: 292-296, 1996.
18. Marguerie C, Bunn CC, Beynon LC, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 77: 1019-1038, 1990.
19. Love LA, Leff RL, Fraser DD, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70: 360-374, 1991.
20. Ghirardello A, Zampieri S, Iaccarino L, et al. Myositis specific and myositis associated autoantibodies in idiopathic inflammatory myopathies: a serologic study of 46 patients. Reumatismo 57: 22-28, 2005.
21. Friedman AW, Targoff IN, Arnett FC. Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis. Semin Arthritis Rheum 26: 459-467, 1996.
22. Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 12: 501-508, 2000.
23. Kudo M, Ihn H, Yamane K, et al. Serum KL-6 in adult patients with polymyositis and dermatomyositis. Rheumatology (Oxford) 39: 632-636, 2000.
24. Ihn H, Asano Y, Kubo M, et al. Clinical significance of serum surfactant protein D (SP-D) in patients with polymyositis/dermatomyositis: correlation with interstitial lung disease. Rheumatology (Oxford) 41: 1268-1272, 2002.
25. Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Chérin P. Antisynthetase syndrome. Joint Bone Spine 70: 161-168, 2003.
26. Tillie-Leblond I, Wislez M, Valeyre D, et al. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 63: 53-59, 2008.
27. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositisdermatomyositis- associated interstitial lung disease. Am J Respir Crit Care Med 164: 1182-1185, 2001.
28. Jankowska M, Butto B, Dȩbska-Ślizień A, Rutkowski B. Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome. Rheumatol Int 27: 775-780, 2007.